Vietnam Ponders Ban On Roche’s Avastin For Metastic Breast Cancer
This article was originally published in PharmAsia News
Vietnam drug authorities said they are considering a ban on Roche’s Avastin (bevacizumab) for treating breast cancer in the wake of U.S. FDA’s similar action.
You may also be interested in...
Comments ahead of the vaccine advisory committee ranged from public health groups opposed to emergency use authorizations, to industry requests for guidance on EUA labeling materials.
"One of the issues that COVID-19 has brought out is, how safe is the production of animal-based food products?"
Positive clinical results in Parkinson’s pave path forward for Japanese firm’s potential istradefylline successor.